Naturex welcomes Rosemary extracts approval as antioxidants by the EU

Naturex welcomes Rosemary extracts approval as antioxidants by the EU.

The directives 2010/67/EU and 2010/69/EU, which respectively establish the purity criteria and scope of use of antioxidant rosemary extracts, have just been published.

Avignon – France, 3rd November 2010. Rosemary extracts are now adopted formally into the EU food additive legislation. It allows food companies to use the label “antioxidant: rosemary extract”, thus helping to fulfil the growing consumer demand for natural food products, free of chemical additives. Thanks to this regulatory update, the rosemary extracts market will be propelled to a new dimension in Europe.

A new momentum for the market This approval is a major step for the European rosemary extracts market since it will considerably expand business opportunities. It will definitely boost further the demand for rosemary extracts as major food companies were waiting for clarification on their regulatory status and the final EU-approval to use rosemary extracts in their products. Naturex sees major opportunities for food preservation within Europe, positioning StabilEnhance® OSR rosemary extracts in the market as a safe, effective and natural alternative to synthetic antioxidants.

The achievement of an ambitious project

  Naturex initiated the registration process of rosemary extracts as EU-approved food antioxidants in 1996. Naturex invested in toxicological studies and supported the whole procedure in collaboration with two other producers, namely Raps and Robertet, bringing together the E.R.E.M.G. (European Rosemary Extracts Manufacturers Group). This approval celebrates the efforts spent by this group. As a result, the four methods of production of rosemary extracts listed in the Directive 2010/67/EU, as well as the purity criteria, are based on the processes developed and used by the members of the E.R.E.M.G..

The establishment of purity criteria and dosage rules

The antioxidant activity of rosemary extracts is consistent with their content in carnosic acid and carnosol, the major oil-soluble antioxidant compounds in rosemary leaves. Per Directive 2010/69/EU, it is the ingoing dosage of total carnosic acid plus carnosol which has to be considered rather than the dosage of the whole rosemary extract. This implies knowing the level of active compounds within the rosemary extracts. This requirement was anticipated by Naturex a long time ago. As the market leader, Naturex owns the required expertise and means to help the food industry to best benefit from the new opportunities offered by this regulatory update.

Naturex will publish its results for the third quarter of 2010 on Tuesday 9 November after the close of trading.
If you would like to receive financial information about Naturex by e-mail, go to: www.actusnews.com
NATUREX has been listed on segment B of Euronext Paris since October 1996.
Number of shares: 6,410,931 (4,884,298 ordinary shares and 1,526,633 preferential shares).
ISIN: FR0000054694 – Reuters: NATU.PA – Bloomberg: NRX:FP.
www.naturex.com

About Naturex:
Naturex is the global leader in specialty plant-based natural ingredients. The company produces and markets natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries. The group has three strategic divisions: Food & Beverage, Nutrition & Health and Personal Care.

Naturex’s sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers with the means to meet the requirements of their end consumers. Its strength lies in its ability to position itself on specific products which constitute niche markets.

Based in Avignon, the group employs around 900 people and realizes over 90% of its sales overseas. Naturex has production units across Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also has 15 sales offices located in Europe, the United States and Asia.